Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Lantern Pharma Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 32 | 35 | +3 |
| Shares | 2.43M | 2.25M | −182.5K (−7.5%) |
| Value | $8.62M | $7.11M | −$1.51M (−17.5%) |
New holders (8)
Institutions that held Lantern Pharma Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 12,624 | $39.9K | 0.00% |
| Group One Trading, L.P. | 2,972 | $9.39K | 0.00% |
| Raymond James Financial Inc | 2,730 | $8.63K | 0.00% |
| Federation des caisses Desjardins du Quebec | 800 | $2.53K | 0.00% |
| Northwestern Mutual Wealth Management Co | 500 | $1.58K | 0.00% |
| Newbridge Financial Services Group, Inc. | 200 | $632 | 0.00% |
| FMR LLC | 74 | $234 | 0.00% |
| Key Financial Inc | 2 | $6 | 0.00% |
Sold out (5)
Institutions that held Lantern Pharma Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Perigon Wealth Management, LLC | 39,387 | $139.4K |
| Sigma Planning Corp | 28,650 | $101.4K |
| Susquehanna International Group, LLP | 14,949 | $52.9K |
| Richards, Merrill & Peterson, Inc. | 975 | $3.45K |
| JPMorgan Chase & Co | 128 | $453 |